Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



PAK4 and NAMPT in Patients With Solid Malignancies or NHL (PANAMA)

Multiple Cancer Types

This study will evaluate the safety, tolerability, and efficacy of oral KPT-9274 for the treatment of patients with advanced solid malignancies or non-Hodgkin's lymphoma (NHL). Currently enrolling melanoma patients in combination with nivolumab, only.
Lymphoma, Miscellaneous, Phase I
I
Berlin, Jordan
NCT02702492
VICCPHI1616

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: